期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
Central nervous system tumors and three-dimensional cell biology: Current and future perspectives in modeling
1
作者 Zaki Abou-Mrad Jolie Bou Gharios +4 位作者 Maya M Moubarak Ahmad Chalhoub Charbel Moussalem Hisham F Bahmad Wassim Abou-Kheir 《World Journal of Stem Cells》 SCIE 2021年第8期1112-1126,共15页
Central nervous system(CNS)tumors are a variety of distinct neoplasms that present multiple challenges in terms of treatment and prognosis.Glioblastoma,the most common primary tumor in adults,is associated with poor s... Central nervous system(CNS)tumors are a variety of distinct neoplasms that present multiple challenges in terms of treatment and prognosis.Glioblastoma,the most common primary tumor in adults,is associated with poor survival and remains one of the least treatable neoplasms.These tumors are highly heterogenous and complex in their nature.Due to this complexity,traditional cell culturing techniques and methods do not provide an ideal recapitulating model for the study of these tumors’behavior in vivo.Two-dimensional models lack the spatial arrangement,the heterogeneity in cell types,and the microenvironment that play a large role in tumor cell behavior and response to treatment.Recently,scientists have turned towards three-dimensional culturing methods,namely spheroids and organoids,as they have been shown to recapitulate tumors in a more faithful manner to their in vivo counterparts.Moreover,tumor-on-a-chip systems have lately been employed in CNS tumor modeling and have shown great potential in both studying the pathophysiology and therapeutic testing.In this review,we will discuss the current available literature on in vitro threedimensional culturing models in CNS tumors,in addition to presenting their advantages and current limitations.We will also elaborate on the future implications of these models and their benefit in the clinical setting. 展开更多
关键词 Central nervous system tumors GLIOBLASTOMA three-dimensional modelling spheroidS ORGANOIDS
下载PDF
构建胃癌三维多细胞球体模型用于药物瘤内穿透的精准评价
2
作者 林子鸣 王义俊 《中国医药指南》 2024年第32期1-4,共4页
目的构建并表征胃癌三维多细胞球体模型,用于评价化疗药物的瘤内穿透。方法将12000个小鼠胃癌MFC细胞系接种于96 U 3D细胞培养板,以构建MFC多细胞肿瘤球体(MFC MCTS);将8000个MFC细胞和4000个小鼠成纤维NIH/3T3细胞系共同接种于96 U 3D... 目的构建并表征胃癌三维多细胞球体模型,用于评价化疗药物的瘤内穿透。方法将12000个小鼠胃癌MFC细胞系接种于96 U 3D细胞培养板,以构建MFC多细胞肿瘤球体(MFC MCTS);将8000个MFC细胞和4000个小鼠成纤维NIH/3T3细胞系共同接种于96 U 3D细胞培养板,以构建MFC-NIH/3T3共培养多细胞肿瘤球体(CO MCTS);通过活细胞成像表征球体的直径、圆度、面积和透光率;通过激光共聚焦成像表征球体微环境和化疗药物(LipoDOX,5.0μg/ml)的瘤内穿透。结果培养5 d时,两种球体的透光率最低,圆度>0.90,直径约为530μm,面积约为0.23 mm^(2)。两种球体模型内均检测到3种微环境荧光探针分布。LipoDOX能相对均匀地穿透MFC MCTS,却在CO MCTS内表现出外多内少的不均匀穿透,药物荧光强度降低约58.3%(P<0.01)。结论本研究构建了两种具有良好圆度、高紧实度、适中直径和面积的胃癌三维多细胞球体模型,两种胃癌球体模型均表现出酸性、缺氧和氧化还原微环境,可精准、高效地评价化疗药物的瘤内穿透。 展开更多
关键词 胃癌 三维多细胞球体模型 瘤内穿透 化疗药物评价
下载PDF
由癌生长模型看治疗对策
3
作者 罗辽复 《内蒙古大学学报(自然科学版)》 CAS CSCD 1995年第6期749-752,共4页
由癌生长模型看治疗对策罗辽复(内蒙古大学理论物理研究室,010021,呼和浩特)TumorGrowthModelandCancerTherapiesLuoLiaofu(LaborataryofTheoreticalP... 由癌生长模型看治疗对策罗辽复(内蒙古大学理论物理研究室,010021,呼和浩特)TumorGrowthModelandCancerTherapiesLuoLiaofu(LaborataryofTheoreticalPhysics,NeiMonggol... 展开更多
关键词 生长模型 接触抑制 单竞争因子 治疗
下载PDF
阻断PD-L1和MEK对非小细胞肺癌多细胞球体模型的治疗作用
4
作者 林吉兴 云天洋 +3 位作者 申磊磊 陈瑞骥 王柏霖 王钰琦 《临床肺科杂志》 2023年第7期1046-1051,共6页
目的观察阻断细胞程序性死亡-配体1(PD-L1)和丝裂原活化的细胞外信号调节激酶(MEK)对非小细胞肺癌(NSCLC)多细胞球体(MTS)模型的治疗作用。方法收集2019年1月~2020年1月的NSCLC患者样本,培养MTS模型,使用流式细胞技术观察MEK抑制剂与抗P... 目的观察阻断细胞程序性死亡-配体1(PD-L1)和丝裂原活化的细胞外信号调节激酶(MEK)对非小细胞肺癌(NSCLC)多细胞球体(MTS)模型的治疗作用。方法收集2019年1月~2020年1月的NSCLC患者样本,培养MTS模型,使用流式细胞技术观察MEK抑制剂与抗PD-L1抗体对NSCLC的MTS模型生长抑制、细胞因子产生和免疫检查点基因表达的影响。结果共成功建立7个MTS模型,成功率63.6%。7个MTS模型MEK、MAPK和PD-L1均呈高表达水平。将7种MTS模型分为空白组、阿特珠单抗组、司美替尼组和阿特珠单抗+司美替尼联合应用组,阿特珠单抗组和司美替尼组产生中度抗增殖作用,细胞死亡中位数为30%和25%,联合应用组表现出高度抗增殖效果,细胞死亡中位数为45%。RT-PCR处理后,联合组IFN-γ、IL-12和IL-6的表达显著增加(P<0.05),PD-L1和CTLA-4表达显著减少(P<0.05),司美替尼和阿特珠单抗组PD-L1表达显著减少(P<0.05)。结论在NSCLC的MTS模型中,双重阻断PD-L1和MEK具有优于单一抑制的疗效。 展开更多
关键词 非小细胞肺癌 细胞程序性死亡-配体1 丝裂原活化的细胞外信号调节激酶 多细胞球体模型 肿瘤免疫治疗
下载PDF
Studies of nanoparticle delivery with in vitro bio-engineered microtissues 被引量:3
5
作者 Mingze Sun Jinhyung Lee +1 位作者 Yupeng Chen Kazunori Hoshino 《Bioactive Materials》 SCIE 2020年第4期924-937,共14页
A variety of engineered nanoparticles,including lipid nanoparticles,polymer nanoparticles,gold nanoparticles,and biomimetic nanoparticles,have been studied as delivery vehicles for biomedical applications.When assessi... A variety of engineered nanoparticles,including lipid nanoparticles,polymer nanoparticles,gold nanoparticles,and biomimetic nanoparticles,have been studied as delivery vehicles for biomedical applications.When assessing the efficacy of a nanoparticle-based delivery system,in vitro testing with a model delivery system is crucial because it allows for real-time,in situ quantitative transport analysis,which is often difficult with in vivo animal models.The advent of tissue engineering has offered methods to create experimental models that can closely mimic the 3D microenvironment in the human body.This review paper overviews the types of nanoparticle vehicles,their application areas,and the design strategies to improve delivery efficiency,followed by the uses of engineered microtissues and methods of analysis.In particular,this review highlights studies on multicellular spheroids and other 3D tissue engineering approaches for cancer drug development.The use of bio-engineered tissues can potentially provide low-cost,high-throughput,and quantitative experimental platforms for the development of nanoparticle-based delivery systems. 展开更多
关键词 NANOPARTICLES Drug delivery In vitro tissue model multicellular spheroid
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部